International Biotechnology Trust as of Sept. 30, 2020
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 53 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Therapeutics Pub SHS | 9.8 | $30M | 389k | 77.68 | |
| Neurocrine Biosciences (NBIX) | 6.9 | $21M | 222k | 96.16 | |
| Gilead Sciences (GILD) | 6.5 | $20M | 321k | 63.14 | |
| ACADIA Pharmaceuticals (ACAD) | 6.5 | $20M | 486k | 41.25 | |
| BioMarin Pharmaceutical (BMRN) | 6.1 | $19M | 248k | 75.96 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 5.7 | $18M | 65k | 271.74 | |
| Ptc Therapeutics I (PTCT) | 4.5 | $14M | 299k | 46.66 | |
| Exelixis (EXEL) | 4.1 | $13M | 527k | 24.41 | |
| Seattle Genetics | 4.1 | $13M | 66k | 195.69 | |
| Biogen Idec (BIIB) | 4.0 | $12M | 44k | 283.23 | |
| Amgen (AMGN) | 3.6 | $11M | 44k | 253.98 | |
| Myokardia | 2.9 | $9.0M | 66k | 136.34 | |
| Biohaven Pharmaceutical Holding | 2.9 | $8.9M | 137k | 65.00 | |
| Alexion Pharmaceuticals | 2.8 | $8.6M | 75k | 114.31 | |
| Halozyme Therapeutics (HALO) | 2.6 | $8.1M | 308k | 26.25 | |
| Acceleron Pharma | 2.6 | $8.0M | 71k | 112.37 | |
| Incyte Corporation (INCY) | 2.3 | $7.0M | 78k | 89.74 | |
| Regeneron Pharmaceuticals (REGN) | 2.1 | $6.4M | 12k | 559.22 | |
| Alnylam Pharmaceuticals (ALNY) | 1.7 | $5.3M | 36k | 145.40 | |
| Iovance Biotherapeutics (IOVA) | 1.5 | $4.8M | 145k | 32.92 | |
| Mirati Therapeutics | 1.4 | $4.5M | 27k | 165.87 | |
| Sarepta Therapeutics (SRPT) | 1.4 | $4.4M | 32k | 140.44 | |
| Immunomedics | 1.4 | $4.2M | 50k | 84.99 | |
| Turning Point Therapeutics I | 1.0 | $3.1M | 35k | 87.14 | |
| Protagonist Therapeutics (PTGX) | 1.0 | $3.0M | 152k | 19.53 | |
| Immunic (IMUX) | 0.7 | $2.3M | 123k | 18.52 | |
| Kalvista Pharmaceuticals (KALV) | 0.7 | $2.2M | 177k | 12.58 | |
| Ascendis Pharma AS Sponsored ADR (ASND) | 0.7 | $2.1M | 14k | 153.99 | |
| Ionis Pharmaceuticals (IONS) | 0.6 | $1.9M | 40k | 47.46 | |
| Crispr Therapeutics Namen Akt (CRSP) | 0.6 | $1.8M | 22k | 83.55 | |
| Blueprint Medicines (BPMC) | 0.6 | $1.8M | 20k | 92.72 | |
| Aurinia Pharmaceuticals (AUPH) | 0.5 | $1.7M | 115k | 14.73 | |
| Sutro Biopharma (STRO) | 0.5 | $1.4M | 139k | 10.03 | |
| Mersana Therapeutics (MRSN) | 0.4 | $1.3M | 72k | 18.61 | |
| Amicus Therapeutics (FOLD) | 0.4 | $1.3M | 95k | 14.12 | |
| Chemocentryx | 0.4 | $1.3M | 24k | 54.75 | |
| Allakos (ALLK) | 0.4 | $1.3M | 16k | 81.47 | |
| Arena Pharmaceuticals | 0.4 | $1.2M | 17k | 74.79 | |
| Global Blood Therapeutics In | 0.4 | $1.2M | 22k | 55.14 | |
| Nektar Therapeutics (NKTR) | 0.4 | $1.1M | 67k | 16.57 | |
| EXACT Sciences Corporation (EXAS) | 0.4 | $1.1M | 11k | 101.96 | |
| Insmed (INSM) | 0.3 | $1.1M | 34k | 32.14 | |
| Uniqure Nv SHS (QURE) | 0.3 | $1.0M | 28k | 36.84 | |
| GW Pharmaceuticals Ads | 0.3 | $993k | 10k | 97.35 | |
| Deciphera Pharmaceuticals (DCPH) | 0.3 | $872k | 17k | 51.29 | |
| Fibrogen (FGEN) | 0.3 | $810k | 20k | 41.12 | |
| Agios Pharmaceuticals (AGIO) | 0.2 | $752k | 22k | 34.98 | |
| Intra Cellular Therapies (ITCI) | 0.2 | $637k | 25k | 25.69 | |
| Bluebird Bio (BLUE) | 0.2 | $593k | 11k | 53.91 | |
| Cytokinetics Com New (CYTK) | 0.2 | $541k | 25k | 21.64 | |
| Esperion Therapeutics (ESPR) | 0.1 | $353k | 9.5k | 37.16 | |
| Zealand Pharma A S Sponsored Adr | 0.1 | $210k | 5.7k | 37.15 | |
| Anaptysbio Inc Common (ANAB) | 0.0 | $148k | 10k | 14.80 |
